Quantcast

Latest Organic chemistry Stories

2014-07-23 23:04:35

A recent initiative by Florida’s law enforcement has nearly rid the state of pill mills, but the use of opiates has been replaced by synthetic drugs. Suncoast Rehab supports Florida lawmakers in removing the presence of these deadly drugs from communities and educating families on their dangers and what to look out for. Spring Hill, FL (PRWEB) July 23, 2014 The Centers for Disease Control and Prevention applauded Florida for 23 percent reduction in prescription drug deaths from 2010 to...

2014-07-23 23:03:28

In its latest blog post, Best Drug Rehabilitation, which offers treatment programs and believes that having family close by during a stay in rehab can make a big difference in whether or not the process is successful, is focusing on a topic that is quickly becoming among the most important of all drug and addiction-related dialogues: opiate abuse facts. (PRWEB) July 23, 2014 In its latest blog post, Best Drug Rehabilitation, which offers treatment programs and believes that having family...

2014-07-23 23:03:03

The cellulose ethers and its derivatives market was estimated at $4,124.17 million in 2013, and is expected to grow by 7.08% till 2019. http://www.marketsandmarkets.com/Market-Reports/cellulose-ethers-market-782.html (PRWEB) July 23, 2014 The report, “Cellulose Ethers Market by Derivative (Methyl, Ethyl, Hydroxyethyl, Hydroxypropyl & Carboxymethyl Cellulose), by Application (Pharmaceuticals, Personal Care, Construction, Food & Beverages, Surface Coatings & Paints) & by...

2014-07-23 16:26:55

British Medical Journal publishes biased article regarding PRADAXA RIDGEFIELD, Conn., July 23, 2014 /PRNewswire/ -- Boehringer Ingelheim (BI) wants to set the record straight following misleading statements that the British Medical Journal (BMJ) published today regarding Pradaxa® (dabigatran etexilate mesylate). We are concerned that this publication may alarm patients and prompt them to stop taking PRADAXA, thereby increasing their risk of stroke. To be clear, many of the allegations made...

2014-07-23 12:31:37

However, Access Barriers Result in Greater Prescribing of Conventional Anticoagulants, According to Findings from Decision Resources Group BURLINGTON, Mass., July 23, 2014 /PRNewswire/ -- Decision Resources Group finds that novel oral anticoagulants (NOACs) such as Xarelto, Boehringer Ingelheim's Pradaxa and Bristol-Myers Squibb/Pfizer's Eliquis are preferred treatments for venous thromboembolism (VTE), atrial fibrillation (AF) and acute coronary syndrome (ACS) among physicians and payers in...

2014-07-23 08:31:41

LONDON, July 23, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it has filed an investigational new drug application ("IND") with respect to its naloxone-based opioid overdose reversal nasal spray. Lightlake also announced today that it has received an additional commitment from the National Institute on Drug Abuse ("NIDA"), part...

2014-07-23 08:30:32

District Court Judge Orders Apotex to Immediately Recall the Authorized Generic from its Direct Customers and to Stop Selling and Supplying the Product PITTSBURGH, July 23, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of New Jersey granted its motion for a temporary restraining order against Apotex Inc. and Apotex Corporation in litigation relating to Paroxetine CR, the authorized generic of GlaxoSmithKline's Paxil(®)...

2014-07-22 08:32:36

Additional Independent Review Board Approvals Expected for Phase 2 Trial (Study 202) SAN DIEGO, July 22, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that it has resumed enrollment and dosing of patients in its ongoing Phase 2 trial (Study 202) evaluating PEGPH20 in patients with pancreatic cancer under the revised clinical protocol agreed to with the FDA in June. PEGPH20 is an investigational PEGylated form of Halozyme's proprietary recombinant...

2014-07-22 08:31:15

RALEIGH, N.C., July 22, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that its Board of Directors has appointed Charles J. (Chuck) Bramlage and Dr. Barry I. Feinberg as members of the Board. http://photos.prnewswire.com/prnvar/20110217/CL49801LOGO Mr. Bramlage is a veteran pharmaceutical industry executive with extensive experience in marketing, sales and other commercial functions. He is currently the Chief Executive Officer of...

2014-07-22 08:31:00

MONMOUTH JUNCTION, N.J., July 22, 2014 /PRNewswire/ -- Vernalis plc (LSE: VER) and Tris Pharma, Inc. today announce the achievement of proof-of-concept (POC) for CCP-08, the third programme to achieve this milestone in their US prescription cough cold collaboration. Under this collaboration, POC requires the successful completion of several activities, including a successful human pilot comparative study against an immediate release reference product. As a result of achieving POC,...


Latest Organic chemistry Reference Libraries

Organometallics
2012-05-17 15:18:17

Organometallics is a peer-reviewed scientific journal published by the American Chemical Society. As of May 2012, the editor-in-chief is John A. Gladysz. Organometallics publishes records in one of the most active fields for organometallic, inorganic, organic, and materials chemists. Articles, communications, mini-reviews, and notes detail the synthesis, structure, bonding, chemical reactivity and reaction mechanisms, and applications of organometallic and organometalloidal compounds....

Synthetic Metals
2012-05-17 14:54:38

Synthetic Metals is a peer-reviewed scientific journal published by Elsevier. It covers all aspects of electronic polymers and electronic molecular materials. It is an international medium for the rapid publication of original research papers, short communications and subject reviews dealing with research on and applications of electronic polymers and electronic molecular materials including novel carbon architectures. Original manuscripts on chemical, electrochemical, electrical, photonic...

More Articles (2 articles) »
Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.